Overview Financials News + Filings Key Docs Charts Transactions Holdings Ownership
All 13F 13D/G Other
Tags Quarterly results CC transcript
|
Sanofi (SNY)
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
09/08/2020 |
GN
| Biopharma Leaders Unite to Stand with Science |
08/17/2020 |
GN
| PRINCIPIA BIOPHARMA INC. SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation of Buyout |
03/27/2020 |
GN
| Sanofi Pasteur and Translate Bio to Collaborate to Develop a Novel mRNA Vaccine Candidate Against COVID-19 |
12/26/2018 |
GN
| Opiant Pharmaceuticals Licenses Novel CB-1 Receptor Antagonist for Treatment of Acute Cannabinoid Overdose from Sanofi |
09/26/2018 |
GN
| New Research Coverage Highlights Sanofi, Amdocs, GlaxoSmithKline plc, BT Group, Sociedad Quimica y Minera S.A, and ARMOUR Residential REIT — Consolidated Revenues, Company Growth, and Expectations for 2018 |
05/22/2018 |
GN
| FDA to review Zynquista™ (sotagliflozin) as potential treatment for type 1 diabetes |
03/27/2018 |
GN
| Consolidated Research: 2018 Summary Expectations for Anheuser-Busch InBev SA/NV, Sanofi, Sogou Inc. Sponsored ADR, Unilever, Janus Capital Group, and Kosmos Energy — Fundamental Analysis, Key Performance Indications |
|
|